Paging Dr. Lilly

Ever find yourself questioning the moral compass of Big Pharma and their partnerships? Brace yourself as we navigate the intricate relationship between Eli Lilly and a telehealth company, dissecting how this could potentially skew prescription practices. With patient care and the integrity of medical advice at stake, we're not shying away from challenging the status quo, predicting the medical community's pushback, and advocating for transparency and patient-focused strategies over profit-driven alliances.

Next we talk with our patient couple Kim and Larry. They open up about their weight loss struggles and how they found success combining nutrition and GLP-1 medication. It's a candid look into the reliance on support systems, the role of medications like GLP-1 agonists, and the often overlooked emotional journey behind managing eating habits. We'll pull back the curtain on the stigmatization attached to medication use in weight management and why it's time to normalize these life-changing aids that can redefine our relationship with food and hunger.

Rounding off, we're strapping on our sneakers to tackle the economics of obesity treatment and the practicality of weaving movement into our daily lives. From ingenious 'movement sprinkles' to the financial burden of medications and surgeries, we're shedding light on accessibility issues and potential policy impacts. Plus, we won't leave you hanging on the topic of hiatal hernias post-gastric sleeve surgery, offering insights into when it's time to consider surgical intervention. Buckle up for a journey through the complexities of health, ethics, and personal well-being.